We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Chiron Off The Hook For Securities Violations

Law360 (February 7, 2006, 12:00 AM EST) -- The U.S. Securities and Exchange Commission has closed its investigation into whether Chiron Corp. violated any federal securities laws, the biotech company said Tuesday.

In October 2004, the SEC began informally investigating Chiron in connection with the unexpected suspension of Chiron's license to manufacture an influenza virus vaccine, Fluviron, by the United Kingdom’s Medicines and Healthcare Products Regulatory Agency. The suspension was due to concerns of contamination.

U.S. securities regulators wanted to know what the company could and should have told investors about its vaccine manufacturing...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.